残余胆固醇联合超敏 C 反应蛋白与急性缺血性脑卒中患者 发病的关系探讨

张 晓冬, 钟 平*
安徽医科大学附属宿州医院

摘要

目的：通过对比观察急性缺血性脑卒中患者与非急性腔隙性脑梗死患者残余胆固醇以及血清 CRP 水平，探讨残余胆固醇
联合超敏 C 反应蛋白与急性缺血性脑卒中患者发病的关系。方法：观察 100 例急性缺血性脑卒中患者及 100 例非急性腔隙性脑梗
死患者的传统血脂指标，计算残余胆固醇以及测定超敏 C 反应蛋白水平，分析比较残余胆固醇、超敏 C 反应蛋白、以及二者联合
对患者发生急性脑卒中的预测价值。结果：急性缺血性脑卒中患者残余胆固醇、超敏 C 反应蛋白水平均高于非急性腔隙性脑梗死
患者，差异均具有统计学意义(P<0.05)。ROC 曲线分析 RC、Hs-CRP、二者联合的 ROC 曲线下面积分别为 0.661、0.686、0.303，
具有统计学意义（p＜0.05）。结论：RC、Hs-CRP、以及二者联合对于缺血性脑卒中的发病有一定预测诊断价值。

关键词

缺血性脑卒中；残余胆固醇；超敏 C 反应蛋白；联合指标；预测价值

参考

[1] Varbo A, Nordestgaard BG. Remnant cholesterol and risk

of ischemic stroke in 112,512 individuals from the general

population. Ann Neurol 2019;85:550-559. [2] VARBO A,BENN M,TYBJÆRG-HANSEN A,et al. Elevated remnant cholesterol causes both low-grade inflammation

and ischemic heart disease,whereas elevated low-density

lipoprotein cholesterol causes ischemic heart disease without

inflammation[J]. Circulation,2013,128(12):1298-1309. [3] Huang X, Wang A, Liu X, Chen S, Zhu Y , Liu Y , Huang

K, Wu J, Chen S,Wu S, Zhao X (2016) Association between high

sensitivity C-reactive protein and prevalence of asymptomatic

carotid artery ste-nosis. Atherosclerosis 246:44–49. [4] 中华医学会神经病学分会,中华医学会神经病学分会

脑血管病学组.中国急性缺血性 脑卒中诊治指南 2018[J]. 中华

神经科杂志,2015,48:246-257. [5] Guidelines for the Prevention of Stroke in Patients With

Stroke and Transient Ischemic Attack 2014-Aguideline for

healthcare professionals from the American heart association/American stroke association[J]. Stroke,2014,45(7): 2160-2236. [6] Franziska Herpich, MD, Fred Rincon, MD, Management of Acute Ischemic Stroke, (Crit Care Med 2020; 48:1654–1663. [7] ZHANG M,GU J,ZHANG C. Hepatitis B virus X protein

bind⁃ ing to hepsin promotes C3 production by inducing IL⁃ 6

secretion from hepatocytes[J]. Oncotarget,2016,7(7):7780⁃ 800. [8] MACH F, BAIGENT C, CATAPANO A L, et al. 2019

ESC/ EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk[J]. Eur Heart J, 2020, 41(1): 111-188. [9] Ference BA, Ginsberg HN, Graham I, Ray KK, Packard

CJ, Bruckert E, Hegele RA,etc,Catapano AL.Low-density

lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A

consensus statement from theEuropean Atherosclerosis Society

Consensus Panel. Eur Heart J,2017;38:2459?2472. [10] NORDESTGAARD B G, VARBO A. Triglycerides and

cardiovascular disease[J]. Lancet, 2014, 384(9943): 626-635. [11] MILLER YI,CHOISH,FANG L,et al. Lipoprotein modification and macrophage uptake:role of pathologic

cholesterol transport in atherogenesis[J]. Subcell Biochem,2010, 51:229-251. [12] LIU L,WEN T,ZHENG X Y,etal. Remnant-like particles ac⁃ celerate endothelial progenitor cells senescence and induce

cellu ⁃ lar dysfunction via an oxidative mechanism[J]. Atherosclerosis,2009,202(2):405-414. [13] Morten Kaltoft, Anne Langsted, etal. T riglycerides and

remnant cholesterol associated with risk of aortic valve

stenosis:Mendelian randomization in the Copenhagen General

Population Study. European Heart Journal (2020) 0, 1–14. [14] Montaner J, Alvarez-Sabin J, Barbera G, et al. Correlation between the expression of proinflammatory cytokines and matrix metalloproteinase in the acute phase of an ischemic

stroke. Rev Neurol 2001;33:115-118. [15] Di Napoli M, Papa F, Bocola V. Prognostic influence of

increased C-reactive protein and fibrinogen levels in ischemic

stroke. Stroke 2001;32:133-138. [16] de Maat MP, Trion A: C-reactive protein as a risk factor versus risk marker. Curr Opin Lipidol 2005, 15:651–657. [17] Varbo A, Benn M, Tybjaerg‑ Hansen A, et al. Elevated

remnant choles‑ terol causes both low‑ grade inflammation and

ischemic heart disease, whereas elevated low‑ density lipoprotein

cholesterol causes ischemic heart disease without inflammation. Circulation. 2013;128:1298–309. [18] Ahmed O, Littmann K, Gustafsson U, et al. Ezetimibe in

combination with simvastatin reduces remnant cholesterol without affecting biliary lipid concentrations in gallstone patients[J]. J Am

Heart Assoc, 2018, 7(24): e9876.